Patents for C07C 237 - Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups (16,118) |
---|
02/18/2009 | EP0842143B3 2-(4-substituted)-benzylamino-2-methyl-propanamide derivatives |
02/18/2009 | CN101367749A A set of mesidino mesitoyl derivant, preparation and application thereof |
02/18/2009 | CN101367748A Amide derivatives, process for production of the same, and method for application thereof as insecticide |
02/18/2009 | CN101367747A Tigecycline without crystal habit and method of preparing the same |
02/17/2009 | US7491844 Therapeutic cyclopentane derivatives |
02/17/2009 | US7491835 Prodrugs of amino acids with affinity for the α2δ-protein |
02/17/2009 | US7491741 Diaminopropionic acid derivatives |
02/17/2009 | US7491707 Synthetic lipid-a-analogs and uses thereof |
02/12/2009 | WO2009018662A1 Renin inhibitors |
02/12/2009 | US20090042958 Composition and method for treating immune-mediated skin disorders |
02/12/2009 | CA2695461A1 Renin inhibitors |
02/11/2009 | EP2021317A1 Contrast agents |
02/10/2009 | US7488841 Composition containing acyl group |
02/10/2009 | US7488755 NMDA receptor agonist; neurodegenerative diseases, cognition activator; autism, schizophrenia, Alzheimer's disease; glycinergic and/or glutaminergic transmission activator |
02/10/2009 | CA2328396C New substituted amides, their production and their use |
02/05/2009 | WO2009018065A2 Novel glucokinase activators and methods of using same |
02/05/2009 | US20090036311 Benzoyl-Substituted Alanines |
02/05/2009 | DE19963179B4 Substituierte 1- und 2-Naphthol-Mannichbasen Substituted 1- and 2-naphthol Mannich bases |
02/04/2009 | CN101360704A Method for the production of aminoalkane acid amides |
02/04/2009 | CN101357893A Ethylene diamine metalloid protease inhibitor and use thereof |
02/04/2009 | CN101357341A Hydrogenation technique rhodium catalyst for producing antibiotic doxycycline and use thereof |
02/04/2009 | CN100457720C 2-propyl valeramide and 2-propyl pentaenuylamide derivative and application used as anti-convulsion medicine |
02/04/2009 | CN100457716C Novel composition containing acyl group |
02/03/2009 | US7485753 Cyclopropane scaffolding moiety having three iodinated phenyl groups bound thereto; less renal toxicity, improved viscosity, iodine concentration and solubility |
01/29/2009 | WO2009013915A1 Inhibitor of plasminogen activator inhibitor-1 |
01/29/2009 | WO2009012741A1 Method for the synthesis of a-ring aromatized acetyl minocyclines |
01/29/2009 | WO2009012656A1 Inhibitors for matrix metalloproteinases, pharmaceutical compositions containing them and their uses |
01/29/2009 | US20090030232 Synthesis of [1-13C]pyruvic acid], [2-13C]pyruvic acid], [3-13C]pyruvic acid] and combinations thereof |
01/29/2009 | US20090030080 Antagonists of the magnesium binding defect as therapeutic agents and methods for treatment of abnormal physiological states |
01/29/2009 | US20090030056 Novel sodium channel blockers |
01/29/2009 | US20090028799 Contrast agents |
01/28/2009 | EP0966443B1 Heteroaryl-hexanoic acid amide derivatives, their preparation and their use as selective inhibitors of mip-1-alpha binding to its ccr1 receptor |
01/28/2009 | CN101352692A Iridium catalyst for hydrogenization technique for producing medicament doxycycline and uses thereof |
01/28/2009 | CN100455572C Dibenzo(b,f)azepine derivatives |
01/28/2009 | CN100455559C Method for reduced preparation of arylamine from aromatic nitro compound |
01/27/2009 | US7482488 (E)-N-(4-methoxy-3-nitrophenyl)-3-(3,4,5-trimethoxyphenyl)-2-propenamide; as antiproliferative agents, radioprotective agents and cytoprotective agents, anticancer agents |
01/27/2009 | US7482487 Phenylaminoethanol derivatives as β2 receptor agonists |
01/27/2009 | US7482483 calixarenes having acyclic isophthalic acid groups attached, used as target for platelet derived growth factors or vascular endothelial growth factors; angiogenesis inhibitors, antiproliferative, antitumor or anticarcinogenic agents |
01/27/2009 | CA2247443C Substituted 4-hydroxy-phenylalcanoic acid derivatives with agonist activity to ppar-gamma |
01/22/2009 | WO2009009812A1 Pleuromutilin derivatives and their use as antimicrobials |
01/22/2009 | US20090023734 Treating cell proliferative disorders |
01/22/2009 | US20090023710 Compound |
01/22/2009 | DE102007034259A1 Verfahren zur Synthese von A-Ring-aromatisierten Acetyl-Minocyclinen A process for the synthesis of A-ring flavored acetyl-minocyclines |
01/22/2009 | CA2693015A1 Pleuromutilin derivatives and their use as antimicrobials |
01/21/2009 | EP2017244A2 Chiral binaphtol derivatives as alanine racemase mimics with powerful hydrogen bond donors: their use for optical resolution and optical inversion |
01/21/2009 | EP2016046A1 Contrast agents |
01/21/2009 | EP2016045A2 Tigeycline crystalline forms and processes for preparation thereof |
01/21/2009 | EP2016044A2 Synthesis of tetracyclines and analogues thereof |
01/21/2009 | EP2016043A1 Methods for reducing 7/9-nitrotetracycline derivatives |
01/21/2009 | EP1517915B1 Prodrugs of excitatory amino acids |
01/21/2009 | EP0951466B1 Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds |
01/21/2009 | CN100453528C Non-symmetrical gelling agent |
01/20/2009 | US7479573 Cationic lipids capable of facilitating transport of biologically active agents or substances into cells; lipid aggregate macromolecular complex interacts with cells making the polyanionic macromolecule available for absorption and uptake by the cell |
01/20/2009 | CA2502856C Intermediates for retroviral protease inhibiting compounds |
01/20/2009 | CA2401048C 2-oxo-1-pyrrolidine derivatives, process for preparing them and their uses |
01/20/2009 | CA2337770C Amide derivatives which are useful as cytokine inhibitors |
01/15/2009 | WO2009009042A1 Methods for synthesizing substituted tetracycline compounds |
01/15/2009 | US20090018116 Therapeutic Compounds |
01/15/2009 | CA2693376A1 Methods for synthesizing substituted tetracycline compounds |
01/14/2009 | EP2014645A1 Pleuromutilin derivatives and their use as antimicrobials |
01/14/2009 | EP1509254B1 New agents for magnetic imaging method |
01/14/2009 | EP1477472B1 Substituted phenylalkanoic acid derivative and use thereof |
01/14/2009 | EP1345899B1 N-substituted amides as NK1 receptor antagonists |
01/14/2009 | CN101346336A 1,3-bis(substituted phenyl)-3-hydroxypropan-1-one or 2-propen-1-one compound, and salt thereof |
01/14/2009 | CN101343242A Acryloyl di-quaternary ammonium salt and preparation thereof |
01/14/2009 | CN100450996C Blood pool agents for nuclear magnetic resonance diagnostics |
01/14/2009 | CN100450994C Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors |
01/13/2009 | US7476680 e.g. 1-[2-hydroxy-3-(quinolin-5-yloxy)-propyl]-piperidine-4-carboxylic acid [4-phenyl-1-(3-phenyl-propyl)-butyl]-amide; multidrug resistance protein or P-glycoprotein modulator; with other therapeutic agent: anticarcinogenic, antibacterial, antiviral, antifungal agents |
01/13/2009 | CA2459175C An improved process for the synthesis of (±)2-amino-n-(2,(2,5-dimethoxyphenyl)-2-hydroxyethyl) acetamide monohydrochloride |
01/08/2009 | WO2009005365A1 Contrast agents |
01/08/2009 | WO2009005364A1 Contrast agents |
01/08/2009 | WO2008102161A3 Crystalline minocycline base and processes for its preparation |
01/07/2009 | EP1667966A4 N-alkylated diaminopropane derivatives as modulators of chemokine receptor activity |
01/07/2009 | EP1357909B1 Il-8 receptor antagonists |
01/07/2009 | CN101337944A P-38 kinase inhibitors |
01/07/2009 | CN101337907A Process for purifying ioversol |
01/07/2009 | CN100448844C Inhibitors of histone deacetylase |
01/07/2009 | CN100448834C A process for resolving, optionally substituted, mandelic acids by salt formation with a chiral base cyclic amide |
01/06/2009 | US7473794 Method for the production of cyclic phosphonic acid anhydrides |
01/06/2009 | CA2421008C Substituted heterocyclic compounds for treating multidrug resistance |
12/31/2008 | EP2007715A2 Tetracycline compounds and methods of treatment |
12/31/2008 | EP2007713A2 Isolation of tetracycline derivatives |
12/31/2008 | EP1051397B1 Method for preparing an n- (aliphatic or aromatic)carbonyl -2-aminoacetamide compound and a cyclyzed compound |
12/31/2008 | CN101336236A Anthranilic acid derivatives useful in treating infection with hepatitis c virus |
12/31/2008 | CN101333175A Method for preparing D-asparagine and D-homoserine |
12/31/2008 | CN101333174A N-bridged selective androgen receptor modulators and methods of use thereof |
12/31/2008 | CN100446749C hair cosmetics, aminocarboxylic acid amide and its producing process |
12/31/2008 | CA2690191A1 4-carboxybenzylamino derivatives as histone deacetylase inhibitors |
12/30/2008 | US7470817 Acyclic and macrocyclic, aliphatic diammonium surfactants for use in forming lipid aggregates for drug delivery of macromolecules; improved versatility among different cell types and broadened range of molecules to be carried |
12/30/2008 | CA2412452C Process for the preparation of substituted octanoyl amides |
12/30/2008 | CA2351703C Novel 4-dedimethylaminotetracycline derivatives |
12/30/2008 | CA2304557C Polyamine transport inhibitors |
12/29/2008 | CA2636734A1 Metal coordinated compositions |
12/25/2008 | US20080319057 2-[[2-[4-(3-Fluoro-benzyloxy)-3-methoxy-phenyl]-ethyl]-isobutylamino]-N-methyl-acetamide, useful in preventing neurological, psychiatric, cardiovascular, inflammatory, ophthalmic, urogenital and gastrointestinal disorders |
12/25/2008 | US20080318255 Fluorescent Labeled Sphingosines |
12/24/2008 | WO2008157162A1 Dipeptide analogs as coagulation factor inhibitors |
12/24/2008 | WO2008156831A2 Renin inhibitors |
12/24/2008 | WO2008156701A2 Hydroxamate inhibitors of insulin-degrading enzyme and uses thereof |
12/24/2008 | WO2008155405A1 Crystalline solid forms |
12/24/2008 | WO2007115185A3 Preparation of chiral amides and amines |